RE: Retreatment with ozurdex for macular edema secondary to retinal vein occlusion

摘要

We thank Dr. de Smet et al for their letter. We understand that several treatment options are available for RVO and we appreciate the scheme that the authors elaborated, considering age, state of the lens, presence of glaucoma and response to treatment, previous cardiovascular and cerebrovascular events, failure to alternate therapies for RVO, and patient compliance.